Type 2 & other diabetes

Validation of a risk prediction model for early chronic kidney disease in patients with type 2 diabetes: Data from the German/Austrian Diabetes Prospective Follow‐up registry

Diabetes Obes MetabPublished Validation study of a risk prediction model

Authors' conclusion

The predictive model achieved moderate discrimination but good calibration in a German/Austrian T2D population, suggesting that the model may be relevant for determining CKD risk.

Study context

Population
Adults aged 39–75 years with T2D, normoalbuminuria and eGFR ≥60 ml/min/1.73m2, DPV registry; mean age 61 years, diabetes duration 6 years, body mass index (BMI) 31.7 kg/m², HbA1c 6.9%; 9.1% diabetic retinopathy, 16.3% smokers
Participants
10,922 adults
Comparison
Risk categories: low vs moderate vs high vs very high risk
Outcome
CKD occurrence (model discrimination; prognostic factors: age, BMI, smoking status, HbA1c)
Follow-up
≈59 months
Methodological detailsregistry cohort, external validation, German/Austrian DPV registry
  • Registry cohort
  • External validation
  • German/Austrian DPV registry

Performance

As reported in the abstract

Developed CKD by risk group · after follow-up
Developed chronic kidney disease (CKD), overall
37.4%
AUC, unadjusted base model
0.58 (95% CI 0.57-0.59)
AUC adjusted for diabetes and follow-up duration
0.69 (95% CI 0.68-0.70)
Increasing risk score correlated with increasing cumulative risk of incident CKD over median 4.5 years
P < 0.0001

Original publication

Validation of a risk prediction model for early chronic kidney disease in patients with type 2 diabetes: Data from the German/Austrian Diabetes Prospective Follow‐up registry. Diabetes Obes Metab. Published 20 December 2022. doi:10.1111/dom.14925

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.